Alphamab Oncology (HK) Limited (3NK.F) Q3 2025 Earnings

28AugConfirmed
Q1 2024
Q3 2024
Q1 2025
Q3 2025
-0.01
-0
-0
0

Details

Expected EPS
N/A
Actual EPS
0.00238923555
Surprise EPS
0
Surprise Percent
+∞%

Description

Alphamab Oncology (HK) Limited (3NK.F) has reported earnings of 0.00238923555 per share for Q3 2025.

0 Comments

Share your thoughts